Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Dynavax Technologies Corp. (NASDAQ: DVAX) closed the day trading at $10.87 down -2.16% from the previous closing price of $11.11. In other words, the price has decreased by -$2.16 from its previous closing price. On the day, 1.55 million shares were traded. DVAX stock price reached its highest trading level at $11.18 during the session, while it also had its lowest trading level at $10.65.
Ratios:
For a better understanding of DVAX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.94 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.32. For the most recent quarter (mrq), Quick Ratio is recorded 13.18 and its Current Ratio is at 14.18. In the meantime, Its Debt-to-Equity ratio is 0.40 whereas as Long-Term Debt/Eq ratio is at 0.39.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on February 01, 2024, initiated with a Neutral rating and assigned the stock a target price of $20.
On September 27, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $22.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 31 ’24 when CANO FRANCIS sold 3,615 shares for $11.93 per share. The transaction valued at 43,127 led to the insider holds 36,905 shares of the business.
Burgess Justin sold 20,526 shares of DVAX for $262,322 on Mar 01 ’24. The Chief Accounting Officer now owns 0 shares after completing the transaction at $12.78 per share. On Jan 04 ’24, another insider, Janssen Robert, who serves as the SVP and CMO of the company, sold 1,500 shares for $15.00 each. As a result, the insider received 22,500 and left with 49,925 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DVAX now has a Market Capitalization of 1424448256 and an Enterprise Value of 944121472. As of this moment, Dynavax’s Price-to-Earnings (P/E) ratio for their current fiscal year is 99.45, and their Forward P/E ratio for the next fiscal year is 29.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.70 while its Price-to-Book (P/B) ratio in mrq is 2.21. Its current Enterprise Value per Revenue stands at 3.781 whereas that against EBITDA is -119.949.
Stock Price History:
Over the past 52 weeks, DVAX has reached a high of $15.15, while it has fallen to a 52-week low of $9.74. The 50-Day Moving Average of the stock is -1.60%, while the 200-Day Moving Average is calculated to be -9.87%.
Shares Statistics:
Over the past 3-months, DVAX traded about 2.10M shares per day on average, while over the past 10 days, DVAX traded about 2095530 shares per day. A total of 131.04M shares are outstanding, with a floating share count of 130.41M. Insiders hold about 0.49% of the company’s shares, while institutions hold 102.53% stake in the company. Shares short for DVAX as of 1724976000 were 18298236 with a Short Ratio of 8.70, compared to 1722384000 on 17892489. Therefore, it implies a Short% of Shares Outstanding of 18298236 and a Short% of Float of 17.06.
